Sales & Earnings In Brief: Revlon, Reckitt, Kao Report At Half-Year Mark
This article was originally published in The Rose Sheet
Executive Summary
Revlon remains optimistic that investments in its Almay brand will deliver, despite the brand’s struggling performance in the second quarter. More financial news in brief.
You may also be interested in...
Reckitt Consumer Health Growth Helps Fuel Pharma Unit Divestment Buzz
Reckitt Benckiser says it will focus on its consumer health business, led by the Mucinex OTC decongestant line, and other core units with strong sales and will review its slumping Rx business, including considering a sale.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.